• The consensus price target for Kimberly-Clark Corporation (NYSE:KMB) has been on a downward trend, indicating a bearish outlook from analysts.
• Despite expected declines in revenue and EPS, stable core demand and productivity may provide support to the stock.
• Analyst Peter Grom from UBS has set a price target of $138, suggesting some analysts see potential for recovery or growth.

Kimberly-Clark Corporation (NYSE:KMB) is a leading player in the personal care and consumer tissue industry. The company operates through three main segments: Personal Care, Consumer Tissue, and K-C Professional. It is renowned for its popular brands like Huggies, Kleenex, and Scott, which serve both household and professional markets.

The consensus price target for Kimberly-Clark's stock has been on a downward trend over the past year. A year ago, the average price target was $129.21, which decreased to $120.38 in the last quarter and further dropped to $104.67 in the past month. This decline indicates a more cautious or bearish outlook from analysts regarding the stock's future performance.

Kimberly-Clark is approaching its Q4 earnings report with expected declines in both revenue and earnings per share (EPS). The company is grappling with challenges such as promotions, tariffs, and foreign exchange (FX) pressures. Despite these hurdles, core demand and productivity remain stable, which may provide some support to the stock.

Analyst Peter Grom from UBS has set a price target of $138 for Kimberly-Clark, which contrasts with the overall downward trend in consensus price targets. This suggests that some analysts still see potential for the stock, possibly due to the company's stable core demand and productivity.

Investors should consider these factors and monitor any upcoming company news or earnings reports that could impact Kimberly-Clark's stock performance and analysts' future price targets. Changes in market conditions, competitive pressures, or company-specific challenges could further influence the stock's outlook.